Allergen-Specific IgG Antibodies Purified from Mite-Allergic Patients Sera Block the IgE Recognition ofDermatophagoides pteronyssinusAntigens: AnIn VitroStudy

Abstract

One of the purposes of specific immunotherapy (SIT) is to modulate humoral immune response against allergens with significant increases in allergen-specific IgG levels, commonly associated with blocking activity. The present study investigated in vitro blocking activity of allergen-specific IgG antibodies on IgE reactivity to Dermatophagoides pteronyssinus (Dpt) in sera from atopic patients. Dpt-specific IgG antibodies were purified by ammonium sulfate precipitation followed by protein-G affinity chromatography. Purity was checked by SDS-PAGE and immunoreactivity by slot-blot and immunoblot assays. The blocking activity was evaluated by inhibition ELISA. The electrophoretic profile of the ammonium sulfate precipitated fraction showed strongly stained bands in ligand fraction after chromatography, compatible with molecular weight of human whole IgG molecule. The purity degree was confirmed by detecting strong immunoreactivity to IgG, negligible to IgA, and no reactivity to IgE and IgM. Dpt-specific IgG fraction was capable of significantly reducing levels of IgE anti-Dpt, resulting in 35%–51% inhibition of IgE reactivity to Dpt in atopic patients sera. This study showed that allergen-specific IgG antibodies purified from mite-allergic patients sera block the IgE recognition of Dermatophagoides pteronyssinus antigens. This approach reinforces that intermittent measurement of serum allergen-specific IgG antibodies will be an important objective laboratorial parameter that will help specialists to follow their patients under SIT.

Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis

“…In humans with AD, ASIT has been associated with the development of allergen‐specific IgG levels, especially IgG1 and IgG4. In some studies, these antibodies (especially IgG4) have been demonstrated to bind to relevant allergen epitopes, thus ‘blocking’ the binding of allergen‐specific IgE . Whether canine IgG subisotypes can mediate a similar blocking effect remains to be determined.…”

Antigenic cross‐reactivity between Schistosoma mansoni and peanut: a role for cross‐reactive carbohydrate determinants (CCDs) and implications for the hygiene hypothesis

“…in schistosome‐endemic areas, the inverse association observed between infection with the parasite and allergies could be due to the anti‐schistosome CCD IgG in some way blocking the activity of allergen‐specific IgE, thereby preventing allergic reactivity. In this context, allergen‐specific immunotherapy is commonly found to induce production of anti‐allergen IgG antibodies, particularly of the IgG4 subclass, and these have been shown to block in vitro reactions mediated by allergen‐specific IgE . IgG antibodies induced by helminth infection may have a similar effect.…”

Extractos alergénicos para inmunoterapia en Latinoamérica

“…Siman et al 41 identifi caron proteínas IgG que pueden bloquear la actividad de la IgE específi ca a péptidos de Der p que se produjeron después de la inmunoterapia por pacientes con rinitis. Velázquez et al 42 compararon en tres grupos (con o sin ITSC y control) los niveles de IL-2, IL-4, IL-5, IL-6, IL-12, IgG4 e interferón gamma.…”